← Leaderboards
Nicholas Marston
Brigham And Women'S Hospital
$818,151
Attributed
$818,151
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $129.6K · FY2018–24$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$818,151 · 2
By mechanism
K08$646,615 · 1
F32$171,536 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Clare M Tempany$31,151,323
- Shamil Sunyaev$29,625,063
- Naomi D Fisher$3,265,682
- Niall John Lennon$26,830,465
- Catherine Racowsky$2,909,607
Others in their field
Other Emerging Leaders on “Coronary Arteriosclerosis”
- Mara Becker · Duke University$6,798,777
- Jesse M Engreitz · Stanford University$6,126,053
- Pradeep Natarajan · Massachusetts General Hospital$5,947,707
- Paul Stefan De Vries · University Of Texas Hlth Sci Ctr Houston$5,585,958
- Norrina Allen · Northwestern University$4,296,034
- James Pankow · University Of Minnesota$4,182,590
Research focus
Coronary ArteriosclerosisGenetic RiskHigh RiskVariantLeadGenetic VariantGenetic PredictorsGenotypeMyocardial InfarctionSecondary PreventionRecurrencePersonalized MedicineCardiovascular SystemClinical TrialsEventGeneticCaringAwardCardiovascular DiseasesCardiologyAtherosclerosisDecision MakingComputational BiologyCollaborations
Grant awards (7)
Discovery and Application of Germline and Somatic Mutations for Risk Prediction and Personalized Therapy to Prevent Recurrent Myocardial Infarction$129,643
K08 · FY2024 · HL · contact PI
Discovery and Application of Germline and Somatic Mutations for Risk Prediction and Personalized Therapy to Prevent Recurrent Myocardial Infarction$129,643
K08 · FY2023 · HL · contact PI
Discovery and Application of Germline and Somatic Mutations for Risk Prediction and Personalized Therapy to Prevent Recurrent Myocardial Infarction$129,643
K08 · FY2022 · HL · contact PI
Discovery and Application of Germline and Somatic Mutations for Risk Prediction and Personalized Therapy to Prevent Recurrent Myocardial Infarction$128,843
K08 · FY2021 · HL · contact PI
Discovery and Application of Germline and Somatic Mutations for Risk Prediction and Personalized Therapy to Prevent Recurrent Myocardial Infarction$128,843
K08 · FY2020 · HL · contact PI
Creating Genetic Risk Scores to Predict Secondary Coronary Events, Response to Ezetimibe Therapy, and Development of Diabetes after Acute Coronary Syndrome$88,158
F32 · FY2019 · HL · contact PI
Creating Genetic Risk Scores to Predict Secondary Coronary Events, Response to Ezetimibe Therapy, and Development of Diabetes after Acute Coronary Syndrome$83,378
F32 · FY2018 · HL · contact PI